PacBio and Lucid Genomics announced a compatibility collaboration to integrate Lucid’s tertiary analysis software with PacBio HiFi long-read sequencing instruments. The partnership aims to streamline data workflows by enabling seamless transfer of processed reads into Lucid’s cloud-native platform for downstream interpretation.

Lucid Genomics joins the PacBio Compatible partner program as an evaluated solution for tertiary analysis, validating interoperability with PacBio HiFi data standards. The program highlights third-party tools optimized for alignment, phasing, variant annotation, methylation analysis and robust visualization.

Researchers can leverage Lucid’s platform to perform variant calling, structural variant detection, methylation pattern analysis and comprehensive clinical interpretation within a unified pipeline. This end-to-end integration reduces setup complexity and accelerates transition from raw reads to actionable insights.

The collaboration expands PacBio’s partner ecosystem, offering laboratories a production-ready tertiary analysis option that mitigates integration risk and supports scalable, cloud-based workflows. Joint customer engagements and technical resources are expected to drive adoption across research and clinical genomics applications.